Literature DB >> 3259038

Altered activation pathways in T lymphocytes infiltrating human solid tumors.

S Miescher1, M Stoeck, T L Whiteside, S Leyvraz, J Ruzicka, A M Schindler, J C Givel, F Mosimann, V von Fliedner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3259038

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  4 in total

1.  Comparison of recombinant-interleukin-2-activated peripheral blood and tumor-infiltrating lymphocytes of patients with epithelial ovarian carcinoma: cytotoxicity, growth kinetics and phenotype.

Authors:  E Lotzová; C A Savary; R S Freedman; C L Edwards; M Morris
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

2.  Impairment of lymphocyte locomotion in the tumor microenvironment and the effect of systemic immunotherapy with liposome-encapsulated muramyl-tripeptide-phosphatidylethanolamine.

Authors:  D Risin; E S Kleinerman; Y Umezu; R P Pizzini; C M Balch; N R Pellis
Journal:  Cancer Immunol Immunother       Date:  1995-01       Impact factor: 6.968

3.  Cytolytic antitumor effector cells in long-term cultures of human tumor-infiltrating lymphocytes in recombinant interleukin 2.

Authors:  T L Whiteside; D S Heo; S Takagi; J T Johnson; S Iwatsuki; R B Herberman
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

4.  CD4+ Th0 cell clones, isolated from a metastatic lymph node of a melanoma patient, possess cytolytic function.

Authors:  M A Imro; C Castagneto; O Bosco; P Modena; L Lanza; F Puppo; G Filaci; F Indiveri; M Scudeletti
Journal:  Cancer Immunol Immunother       Date:  1995-10       Impact factor: 6.968
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.